Emerging and Emerged Pathogenic Candida Species: Beyond the Candida albicans Paradigm
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Many ascomycete yeast species from the Candida genus are widely distributed in nature and act as common saprophytic constituents of the normal human microflora. However, some of these fungal species can also become opportunistic pathogens following a transition from a commensal to a pathogenic phase, induced by alterations in the host environment. Candida species thereby rarely trigger infection in healthy people, but take advantage of a locally or systematically impaired immune system to proliferate in the host and cause diseases termed ‘‘candidiasis.’’ Such fungal infections can be subdivided into three major groups: cutaneous (skin and its appendages), mucosal (oropharyngeal, esophageal, and vulvovaginal) and systemic (bloodstream infections, i.e., candidemia and other forms of invasive candidiasis [IC]). While superficial candidiasis (cutaneous and mucosal) is often observed in AIDS patients, oropharyngeal thrush and vaginitis are more frequently seen in immunocompetent infants and adult women, respectively. Candidemia and IC are common in cancer patients or in transplant individuals following immunosuppression. Candidiasis currently represents the fourth leading cause of nosocomial infections, at 8% to 10%, and mortality due to systemic candidiasis remains high, ranging from 15% to 35% depending on the infecting Candida species [1]. Although Candida albicans remains the most frequently isolated agent of candidiasis, non-albicans Candida (NAC) species now account for a substantial part of clinical isolates collected worldwide in hospitals. NAC species of particular clinical importance include Candida glabrata, Candida tropicalis, Candida parapsilosis, and Candida krusei (synonym: Issatchenkia orientalis), as well as the less-prominent species Candida guilliermondii, Candida lusitaniae, Candida kefyr, Candida famata (synonym: Debaryomyces hansenii), Candida inconspicua, Candida rugosa, Candida dubliniensis, and Candida norvegensis (Table 1). A complementary set of about 20 opportunistic NAC species is also known, but exhibits lower isolation rates [2].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to C. auris, which truly is an emerging pathogen, Candida spp. that were defined before as “emerging”77 (ie, C. kefyr, C. guilliermondii, C. lusitaniae, C. dubliniensis, C. famata, C. inconspicua, C. rugosa, C. norvegiensis), may have in fact already “emerged” due to better diagnostic differentiation methods, or were selected by the broad use of antifungal treatment and prophylaxis.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“Candidiasis currently represents the fourth leading cause of nosocomial infections, at 8% to 10%, and mortality due to systemic candidiasis remains high, ranging from 15% to 35% depending on the infecting Candida species [1].”
BackgroundEvolution of pathogenicity and sexual reproduction in eight Candida genomes
Butler, G., Rasmussen, M. D., Lin, M. F., Santos, M. A. S., Sakthikumar, S., Munro, C. A., Rheinbay, E., Grabherr, M., Forche, A., Reedy, J. L., et al. (2009) · Nature · doi:10.1038/nature08064 · Cited by 1,065 · cited 1×
“These genome resources have provided new insights into gene family evolution within Candida species and identified gene families enriched in the most common pathogenic NAC species [21].”
BackgroundSilva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00278.x · Cited by 969
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
The diploid genome sequence of Candida albicans
Jones, T., Federspiel, N. A., Chibana, H., Dungan, J., Kalman, S., Magee, B. B., Newport, G., Thorstenson, Y. R., Agabian, N., Magee, P. T., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401648101 · Cited by 768
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Krcmery, V., & Barnes, A. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1151 · Cited by 733
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718 · cited 6×
“norvegensis, although rarely isolated, are now considered emerging NAC species, as their isolation rate has increased between 2- and 10-fold over the last 15 years [2].”
BackgroundInfluentialA fungal phylogeny based on 42 complete genomes derived from supertree and combined gene analysis.
(2006) · BMC Evolutionary Biology · doi:10.1186/1471-2148-6-99 · Cited by 475
Fanning, S., & Mitchell, A. P. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002585 · Cited by 465 · cited 1×
“albicans from the end of the 20 century shed light on the molecular mechanisms involved in drug resistance [11], biofilm formation [12], adherence [13], yeasthyphal switching and its role in virulence [14], and sexual mating [15,16].”
BackgroundEvidence for Mating of the "Asexual" Yeast Candida albicans in a Mammalian Host
Hull, C. M., Raisner, R. M., & Johnson, A. D. (2000) · Science · doi:10.1126/science.289.5477.307 · Cited by 460
Cited by
The Candida Pathogenic Species Complex
Turner, S. A., & Butler, G. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019778 · Cited by 336
Immune defence to invasive fungal infections: A comprehensive review
Pathakumari, B., Liang, G., & Liu, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110550 · Cited by 264
Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris
Chatterjee, S., Alampalli, S. V., Nageshan, R. K., Chettiar, S. T., Joshi, S., & Tatu, U. S. (2015) · BMC Genomics · doi:10.1186/s12864-015-1863-z · Cited by 247
“Recently invasive non albicans candidiasis cases have been reported from many parts of the world [8–11].”
Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth
Haque, F., Alfatah, M., Ganesan, K., & Bhattacharyya, M. S. (2016) · Scientific Reports · doi:10.1038/srep23575 · Cited by 189
Molecular diagnostics in medical mycology
Wickes, B. L., & Wiederhold, N. P. (2018) · Nature Communications · doi:10.1038/s41467-018-07556-5 · Cited by 188
Diagnosis and Treatment of Invasive Candidiasis
Barantsevich, N., & Barantsevich, E. (2022) · Antibiotics · doi:10.3390/antibiotics11060718 · Cited by 178
Corvilain, E., Casanova, J.-L., & Puel, A. (2018) · Journal of Clinical Immunology · doi:10.1007/s10875-018-0539-2 · Cited by 169
Ultrastructural analysis of Candida albicans when exposed to silver nanoparticles
Vazquez-Muñoz, R., Avalos-Borja, M., & Castro-Longoria, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108876 · Cited by 168
“Candida albicans is a dimorphic fungus which is present as an important component of the normal flora in healthy people [5], but in conditions of a weakened immune system Candida becomes an opportunistic pathogen following a transition from a commensal to a pathogenic phase [6].”
BackgroundInfluentialGeddes‐McAlister, J., & Shapiro, R. S. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13739 · Cited by 159
Shih, P.-Y., Liao, Y.-T., Tseng, Y.-K., Deng, F.-S., & Lin, C.-H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00602 · Cited by 156
Hoenigl, M., Salmanton-García, J., Egger, M., Gangneux, J.-P., Bicanic, T., Arikan-Akdagli, S., Alastruey-Izquierdo, A., Klimko, N., Barac, A., Özenci, V., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00872-6 · Cited by 152
Recent trends in molecular diagnostics of yeast infections: from PCR to NGS
Consortium OPATHY, Arastehfar, A., Boekhout, T., Butler, G., De Cesare, G. B., Dolk, E., Gabaldón, T., Hafez, A., Hube, B., Hagen, F., et al. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz015 · Cited by 131
The role of Lactobacillus species in the control of Candida via biotrophic interactions
Zangl, I., Pap, I.-J., Aspöck, C., & Schüller, C. (2020) · Microbial Cell · doi:10.15698/mic2020.01.702 · Cited by 124
Drug resistance mechanisms and their regulation in non-albicans Candida species
Kołaczkowska, A., & Kołaczkowski, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv445 · Cited by 87
Hybridization and emergence of virulence in opportunistic human yeast pathogens
Mixão, V., & Gabaldón, T. (2018) · Yeast · doi:10.1002/yea.3242 · Cited by 90
Johansen, P. G., Owusu‐Kwarteng, J., Parkouda, C., Padonou, S. W., & Jespersen, L. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01789 · Cited by 111
Epidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
“75,76 In contrast to C. auris , which truly is an emerging pathogen, Candida spp. that were defined before as “emerging” 77 (ie, C. kefyr, C. guilliermondii, C. lusitaniae, C. dubliniensis, C. famata, C. inconspicua, C. rugosa, C. norvegiensis ), may have in fact already “emerged” due to better…”
ResultBiotechnological applications of the non-conventional yeast Meyerozyma guilliermondii
Yan, W., Gao, H., Qian, X., Jiang, Y., Zhou, J., Dong, W., Xin, F., Zhang, W., & Jiang, M. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107674 · Cited by 86
Evolutionary genomics of yeast pathogens in the Saccharomycotina
Gabaldón, T., Naranjo-Ortíz, M. A., & Marcet-Houben, M. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fow064 · Cited by 105
Antifungal Activity of Resveratrol Derivatives against Candida Species
Houillé, B., Papon, N., Boudesocque, L., Bourdeaud, E., Besseau, S., Courdavault, V., Enguehard-Gueiffier, C., Delanoue, G., Guérin, L., Bouchara, J.-P., et al. (2014) · Journal of Natural Products · doi:10.1021/np5002576 · Cited by 88
Self-citationHyposalivation, oral health, and Candida colonization in independent dentate elders
Buranarom, N., Komin, O., & Matangkasombut, O. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242832 · Cited by 98
Hybrid histidine kinases in pathogenic fungi
Defosse, T. A., Sharma, A., Mondal, A. K., de Bernonville, T. D., Latgé, J., Calderone, R., Giglioli‐Guivarc’h, N., Courdavault, V., Clastre, M., & Papon, N. (2015) · Molecular Microbiology · doi:10.1111/mmi.12911 · Cited by 97
Self-citationLindberg, E., Hammarström, H., Ataollahy, N., & Kondori, N. (2019) · Scientific Reports · doi:10.1038/s41598-019-40280-8 · Cited by 84
Sadeghi, G., Ebrahimi-Rad, M., Mousavi, S. F., Shams-Ghahfarokhi, M., & Razzaghi-Abyaneh, M. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2017.12.008 · Cited by 96
Ebani, V. V., Nardoni, S., Bertelloni, F., Pistelli, L., & Mancianti, F. (2018) · Molecules · doi:10.3390/molecules23071668 · Cited by 95
El-Baz, A. M., Mosbah, R., Goda, R. M., Mansour, B., Sultana, T., Dahms, T. E. S., & El-Ganiny, A. M. (2021) · Antibiotics · doi:10.3390/antibiotics10010081 · Cited by 93
da Silva, P. M., de Moura, M. C., Gomes, F. S., Trentin, D. D. S., de Oliveira, A. P. S., de Mello, G. S. V., Pitta, M. G. D. R., Rêgo, M. J. B. D. M., Coelho, L. C. B. B., Macêdo, A. J., et al. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.12.039 · Cited by 91
Evaluation of antifungal effect of iron‐oxide nanoparticles against different Candida species
Seddighi, N. S., Salari, S., & Izadi, A. (2017) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2017.0025 · Cited by 89
Szweda, P., Gucwa, K., Kurzyk, E., Romanowska, E., Dzierżanowska‐Fangrat, K., Zielińska‐Jurek, A., Kuś, P. M., & Milewski, S. (2014) · Indian Journal of Microbiology · doi:10.1007/s12088-014-0508-2 · Cited by 88
Freire, P. L. L., Albuquerque, A. D. J. D. R., Farias, I. A. P., da Silva, T. G., Aguiar, J. D. S., Galembeck, A., Flores, M. A. P., Sampaio, F. C., Stamford, T. C. M., & Rosenblatt, A. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.09.052 · Cited by 86
Dominguez, E., Zarnowski, R., Sanchez, H., Covelli, A. S., Westler, W. M., Azadi, P., Nett, J., Mitchell, A. P., & Andes, D. R. (2018) · mBio · doi:10.1128/mbio.00451-18 · Cited by 77
Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species
Whibley, N., & Gaffen, S. L. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.025 · Cited by 77
Aarti, C., Khusro, A., Varghese, R., Arasu, M. V., Agastian, P., Al-Dhabi, N. A., Soundharrajan, I., & Choi, K. C. (2018) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2018.02.014 · Cited by 75
Pre-clinical Imaging of Invasive Candidiasis Using ImmunoPET/MR
Morad, H. O. J., Wild, A., Wiehr, S., Davies, G. E., Maurer, A., Pichler, B. J., & Thornton, C. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01996 · Cited by 71
Tóth, L., Kele, Z., Borics, A., Nagy, L. G., Váradi, G., Virágh, M., Takó, M., Vágvölgyi, C., & Galgóczy, L. (2016) · AMB Express · doi:10.1186/s13568-016-0250-8 · Cited by 65
Antibiofilm, anti cancer and ecotoxicity properties of collagen based ZnO nanoparticles
Vijayakumar, S., & Vaseeharan, B. (2018) · Advanced Powder Technology · doi:10.1016/j.apt.2018.06.013 · Cited by 70
Candida lusitaniae: Biology, Pathogenicity, Virulence Factors, Diagnosis, and Treatment
Mendoza-Reyes, D. F., Gómez-Gaviria, M., & Mora-Montes, H. M. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s383785 · Cited by 69
Cameron, S. J. S., Bolt, F., Perdones-Montero, Á., Rickards, T., Hardiman, K., Abdolrasouli, A., Burke, A., Bodai, Z., Karancsi, T., Simon, D., et al. (2016) · Scientific Reports · doi:10.1038/srep36788 · Cited by 69
Oral Candida colonization in xerostomic postradiotherapy head and neck cancer patients
Tarapan, S., Matangkasombut, O., Trachootham, D., Sattabanasuk, V., Talungchit, S., Paemuang, W., Phonyiam, T., Chokchaitam, O., Mungkung, O., & Lam‐ubol, A. (2019) · Oral Diseases · doi:10.1111/odi.13151 · Cited by 68
Muthamil, S., Devi, V. A., Balasubramaniam, B., Balamurugan, K., & Pandian, S. K. (2018) · Journal of Basic Microbiology · doi:10.1002/jobm.201700529 · Cited by 66
Gutiérrez, J. A., Caballero, S., Díaz, L. A., Guerrero, M., Ruiz, J., & Ortiz, C. C. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00511 · Cited by 65
Candida albicans enhances meropenem tolerance of Pseudomonas aeruginosa in a dual-species biofilm
Alam, F., Catlow, D., Maio, A. D., Blair, J. M. A., & Hall, R. A. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz514 · Cited by 65
Ferreira, G. R. S., Brito, J. D. S., Procópio, T. F., Santos, N. D. D. L., de Lima, B. J. R. C., Coelho, L. C. B. B., Navarro, D. M. D. A. F., Paiva, P. M. G., Soares, T., de Moura, M. C., et al. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.08.027 · Cited by 64
Liu, Y., Lu, J. N., Sun, J. Y., Zhu, X., Zhou, L., Lu, Z., & Lu, Y. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10117-5 · Cited by 64
Chatterjee, G., Sankaranarayanan, S. R., Guin, K., Thattikota, Y., Padmanabhan, S., Siddharthan, R., & Sanyal, K. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005839 · Cited by 63
Parker, R. A., Gabriel, K. T., Graham, K., Butts, B. K., & Cornelison, C. T. (2022) · Pathogens · doi:10.3390/pathogens11080821 · Cited by 61
Gentamicin synergises with azoles against drug-resistant Candida albicans
Lü, M., Yu, C., Cui, X., Shi, J., Yuan, L., & Sun, S. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.09.012 · Cited by 59
The Evolving Landscape of Fungal Diagnostics, Current and Emerging Microbiological Approaches
Weiss, Z., Leon, A., & Koo, S. (2021) · Journal of Fungi · doi:10.3390/jof7020127 · Cited by 57
Vaginal Candida albicans infections: host–pathogen–microbiome interactions
Valentine, M., Wilson, D., Gresnigt, M. S., & Hube, B. (2025) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaf013 · Cited by 54
Implicating Dysbiosis of the Gut Fungal Microbiome in Uveitis, an Inflammatory Disease of the Eye
Jayasudha, R., Chakravarthy, S. K., Prashanthi, G. S., Sharma, S., Tyagi, M., & Shivaji, S. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-26426 · Cited by 54
Al-Baqsami, Z. F., Ahmad, S., & Khan, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-63240-z · Cited by 49
Vaccine immunity against fungal infections
Nanjappa, S. G., & Klein, B. S. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.014 · Cited by 47
Moradpoor, H., Safaei, M., Golshah, A., Mozaffari, H. R., Sharifi, R., Imani, M. M., & Mobarakeh, M. S. (2021) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2021.108748 · Cited by 52
The epidemiology of Candida species in the Middle East and North Africa
Ghazi, S., Rafei, R., Osman, M., El Safadi, D., Mallat, H., Papon, N., Dabboussi, F., Bouchara, J.-P., & Hamze, M. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.07.006 · Cited by 50
Self-citationThe Role of B-Cells and Antibodies against Candida Vaccine Antigens in Invasive Candidiasis
Shukla, M., Chandley, P., & Rohatgi, S. (2021) · Vaccines · doi:10.3390/vaccines9101159 · Cited by 48
Jaromin, A., Żarnowski, R., Pįętka-Ottlik, M., Andes, D. R., & Gubernator, J. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0337 · Cited by 45
Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland
Szweda, P., Gucwa, K., Romanowska, E., Dzierz˙anowska-Fangrat, K., Naumiuk, Ł., Brillowska-Da˛browska, A., Wojciechowska-Koszko, I., & Milewski, S. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000062 · Cited by 43
Costa, C., Ribeiro, J., Miranda, I. M., Silva-Dias, A., Cavalheiro, M., Costa-de-Oliveira, S., Rodrigues, A. G., & Teixeira, M. C. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00526 · Cited by 43
Development of a CRISPR-Cas9 System for Efficient Genome Editing of Candida lusitaniae
Norton, E. L., Sherwood, R. K., & Bennett, R. J. (2017) · mSphere · doi:10.1128/msphere.00217-17 · Cited by 43
Self-citationAntifungal susceptibility profiles of rare ascomycetous yeasts
Hansen, A. P., Lass‐Flörl, C., Lackner, M., Rare Yeast Study Group, Aigner, M., Alastruey‐Izquierdo, A., Arıkan-Akdağlı, S., Bader, O., Becker, K., Boekhout, T., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz231 · Cited by 43
Cavalheiro, M., Costa, C., Silva-Dias, A., Miranda, I. M., Wang, C., Pais, P., Pinto, S. N., Mil-Homens, D., Sato-Okamoto, M., Takahashi-Nakaguchi, A., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00995-18 · Cited by 42
Fungal cell wall components modulate our immune system
Briard, B., Fontaine, T., Kanneganti, T.-D., Gow, N. A. R., & Papon, N. (2021) · The Cell Surface · doi:10.1016/j.tcsw.2021.100067 · Cited by 42
Self-citationTracing the Origin of Invasive Fungal Infections
Papon, N., Bougnoux, M., & d’Enfert, C. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.01.007 · Cited by 42
Self-citationBioactivity and Molecular Docking Studies of Derivatives from Cinnamic and Benzoic Acids
Pérez‐Castillo, Y., Lima, T. C., Ferreira, A. R., da Silva, C. R., Campos, R. D. S., Neto, J. B. D. A., Magalhães, H. I. F., Cavalcanti, B. C., Júnior, H. V. N., & de Sousa, D. P. (2020) · BioMed Research International · doi:10.1155/2020/6345429 · Cited by 42
Ke, C.-L., Liao, Y.-T., & Lin, C.-H. (2021) · Virulence · doi:10.1080/21505594.2020.1870082 · Cited by 41
“systemic infections, particularly in immunocompromised patients [15,16].”
Petrović, S., Radunović, M., Barać, M., Pfićer, J. K., Pavlica, D., Arsić-Arsenijević, V. S., & Pucar, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210527 · Cited by 41
Shukla, M., & Rohatgi, S. (2020) · Infection and Immunity · doi:10.1128/iai.00312-20 · Cited by 41
Monteiro, P. T., Pais, P., Costa, C., Manna, S., Sá-Correia, I., & Teixeira, M. C. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw817 · Cited by 40
The long non-coding RNA landscape of Candida yeast pathogens
Hovhannisyan, H., & Gabaldón, T. (2021) · Nature Communications · doi:10.1038/s41467-021-27635-4 · Cited by 39
Derivates of the Antifungal Peptide Cm-p5 Inhibit Development of Candida auris Biofilms In Vitro
Kubiczek, D. H., Raber, H. F., González-García, M., Morales-Vicente, F., Ständker, L., Otero‐González, A. J., & Rosenau, F. (2020) · Antibiotics · doi:10.3390/antibiotics9070363 · Cited by 38
Microbial diversity and proxy species for human impact in Italian karst caves
Biagioli, F., Coleine, C., Piano, E., Nicolosi, G., Poli, A., Prigione, V., Zanellati, A., Varese, C., Isaia, M., & Selbmann, L. (2023) · Scientific Reports · doi:10.1038/s41598-022-26511-5 · Cited by 37
Pais, P., Costa, C., Cavalheiro, M., Romão, D., & Teixeira, M. C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00131 · Cited by 37
Patriota, L. L. D. S., Procópio, T. F., Souza, M. F. D. D., de Oliveira, A. P. S., Carvalho, L. V. D. N., Pitta, M. G. D. R., Rêgo, M. J. B. D. M., Paiva, P. M. G., Pontual, E. V., & Napoleão, T. H. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00611 · Cited by 36
Hovhannisyan, H., Saus, E., Księżopolska, E., & Gabaldón, T. (2020) · mSphere · doi:10.1128/msphere.00282-20 · Cited by 34
Al-Tekreeti, A. R. A., Al-Halbosiy, M. M. F., Dheeb, B. I., Hashim, A. J., Hussain, A. F., & Mohammad, F. I. (2017) · Arabian Journal for Science and Engineering · doi:10.1007/s13369-017-2762-1 · Cited by 34
Lam‐ubol, A., Matangkasombut, O., Trachootham, D., Tarapan, S., Sattabanasuk, V., Talungchit, S., Paemuang, W., Phonyiam, T., Chokchaitam, O., & Mungkung, O. (2020) · Clinical Oral Investigations · doi:10.1007/s00784-020-03484-1 · Cited by 33
Budzyńska, A., Sadowska, B., Więckowska-Szakiel, M., & Różalska, B. (2014) · Acta Biochimica Polonica · doi:10.18388/abp.2014_1932 · Cited by 33
Francesca, N., Carvalho, C., Sannino, C., Guerreiro, M. A., Almeida, P., Settanni, L., Massa, B., Sampaio, J. P., & Moschetti, G. (2014) · FEMS Yeast Research · doi:10.1111/1567-1364.12179 · Cited by 33
Differential Regulation of Myeloid-Derived Suppressor Cells by Candida Species
Singh, A., Lelis, F., Braig, S., Schäfer, I., Hartl, D., & Rieber, N. P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01624 · Cited by 33
Biotechnological potential of the fungal CTG clade species in the synthetic biology era
Papon, N., Courdavault, V., & Clastre, M. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.10.006 · Cited by 33
Self-citationFungal Enzyme‐Responsive Hydrogel Drug Delivery Platform for Triggered Antifungal Release
Vera‐González, N., Deusenbery, C. B., LaMastro, V., & Shukla, A. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401157 · Cited by 32
Yao, S., Feng, Y., Zhang, Y., & Feng, J. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.11.033 · Cited by 32
Husni, R., Zerdan, M. B., Samaha, N. L., Helou, M. C., Mahfouz, Y., Saniour, R., Hourani, S., Kolanjian, H., Afif, C., Azar, E., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1115055 · Cited by 32
Polizzotto, G., Barone, E., Ponticello, G., Fasciana, T., Barbera, D., Corona, O., Amore, G., Giammanco, A., & Oliva, D. (2016) · Letters in Applied Microbiology · doi:10.1111/lam.12599 · Cited by 32
El-Ganiny, A. M., Kamel, H. A., Yossef, N. E., Mansour, B., & El-Baz, A. M. (2022) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2022.01.011 · Cited by 30
Seddik, H. A., Ceugniez, A., Bendali, F., Cudennec, B., & Drider, D. (2015) · Archives of Microbiology · doi:10.1007/s00203-015-1152-x · Cited by 30
Stabili, L., Acquaviva, M. I., Cavallo, R. A., Gerardi, C., Narracci, M., & Pagliara, P. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/7891748 · Cited by 29
Kumar, D., Banerjee, T., Chakravarty, J., Sk, S., Dwivedi, A. K., & Tilak, R. (2016) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.188320 · Cited by 29
Tocci, N., Perenzoni, D., Iamonico, D., Fava, F., Weil, T., & Mattivi, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00382 · Cited by 29
Galgóczy, L., Yap, A., & Marx, F. (2019) · Israel Journal of Chemistry · doi:10.1002/ijch.201800168 · Cited by 29
Chew, S. Y., Brown, A. J. P., Lau, B. Y. C., Cheah, Y. K., Ho, K. L., Sandai, D. A., Hassan, Y., & Than, L. T. L. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-020-00700-8 · Cited by 28
Kosikowska, P., Pikuła, M., Langa, P., Trzonkowski, P., Obuchowski, M., & Lesner, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140377 · Cited by 28
Laser induced breakdown spectroscopy for the discrimination of Candida strains
Manzoor, S., Ugena, L., Tornero-Lopéz, J., Martín, H., Molina, M., Camacho, J. J., & Cáceres, J. O. (2016) · Talanta · doi:10.1016/j.talanta.2016.04.030 · Cited by 28
Kullberg, B. J., Vasquez, J., Mootsikapun, P., Nucci, M., Paiva, J.-A., Garbino, J., Yan, J. L., Aram, J. A., Capparella, M. R., Conte, U., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx116 · Cited by 27
Thornton, C. R., Ryder, L. S., Cocq, K. L., & Soanes, D. M. (2014) · Environmental Microbiology · doi:10.1111/1462-2920.12470 · Cited by 26
Predoi, D., Ciobanu, C. S., Iconaru, S. L., & Predoi, M. V. (2023) · Coatings · doi:10.3390/coatings13020409 · Cited by 26
Zhao, Y. Y., Chan, J. F., Tsang, C., Wang, H., Guo, D., Pan, Y., Xiao, Y., Yue, N., Chen, J. H.-K., Lau, S. K. P., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01985-15 · Cited by 26
Corte, L., Roscini, L., Colabella, C., Tascini, C., Leonildi, A., Sozio, E., Menichetti, F., Merelli, M., Scarparo, C., Meyer, W., et al. (2016) · Scientific Reports · doi:10.1038/srep26860 · Cited by 26
Dynamics of Mixed– Candida Species Biofilms in Response to Antifungals
Vipulanandan, G., Herrera, M. L., Wiederhold, N. P., Li, X., Mintz, J. D., Wickes, B. L., & Kadosh, D. (2017) · Journal of Dental Research · doi:10.1177/0022034517729351 · Cited by 26
Scordino, F., Giuffrè, L., Barberi, G., Marino‐Merlo, F., Orlando, M. G., Giosa, D., & Romeo, O. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00679 · Cited by 26
Metadata
- Authors
- Papon, N., Courdavault, V., Clastre, M., & Bennett, R. J.
- Affiliations
- Université de Tours (FR)
- Brown University (US)
- Corresponding author
- Papon, Nicolas
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-09-26
- Volume
- 9
- Issue
- 9
- Pages
- e1003550
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3784480
- OpenAlex
- W2080591858
- Cited by
- 314
- References
- 28
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 24 · 2023: 25 · 2022: 27 · 2021: 36 · 2020: 20 · 2019: 30 · 2018: 29 · 2017: 23 · 2016: 31 · 2015: 18 · 2014: 20 · 2013: 1
- FWCI
- 16.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Essex
- Broad Institute
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- non-albicans Candida, Candida albicans, candidiasis, invasive candidiasis, candidemia, opportunistic fungal pathogens, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, Candida guilliermondii, Candida lusitaniae, Candida kefyr, Debaryomyces hansenii, Candida inconspicua, Candida rugosa, Candida dubliniensis, Candida norvegensis, cutaneous candidiasis, mucosal candidiasis, vaginal candidiasis, nosocomial infections, immunocompromised patients, commensal to pathogen transition
- MeSH terms
- Animals, Candida albicans, Candidiasis, Humans, Communicable Diseases, Emerging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.